Conditioned serum in vitro treatment of chondrocyte pellets and osteoarthritic explants
Open Access
- 6 June 2022
- journal article
- research article
- Published by Wiley in Equine Veterinary Journal
- Vol. 55 (2) , 325-335
Abstract
Background: Autologous conditioned serum (ACS) is used to treat osteoarthritis in horses, although its effects are not fully investigated.Objectives: To investigate the effects of equine serum and conditioned serum on chondrocytes stimulated with interleukin (IL)‐1β and cartilage explants with mild osteoarthritis.Study design: In vitro experimental study.Methods: The effect of three different serum preparations (unincubated control [PS], serum incubated 24 h [PS24h] and serum incubated 24 h in ACS containers [PCS]) pooled from lame horses were tested in two in vitro models. IL‐1β and IL‐1 receptor antagonist (IL‐1Ra) concentrations were measured in all sera. In model 1, chondrocyte pellet cultures were stimulated with IL‐1β prior to treatment with the serum preparations for 2 and 48 h. Microarray, polymerase chain reaction, and matrix metallopeptidase‐13 analyses were performed. In model 2, cartilage explants from horses with structural osteoarthritis were treated with PS or PCS on days 0, 6 and 12, or left untreated, and evaluated at day 24 using the OARSI grading scale for histological evaluation of articular cartilage.Results: The IL‐1Ra concentration in PS24h and PCS was significantly higher than in PS. In model 1, inflammation‐ and cartilage matrix degradation‐related genes were upregulated after 48 h in all treatment groups versus untreated controls. Cartilage matrix molecules, aggrecan and collagens, were downregulated in PS24h‐ and PCS‐treated pellets versus untreated controls. Growth factor signalling genes were upregulated—FGF7 in all treatment groups, BMP2 in PS24h‐, and INHBA in PCS‐treated—compared with untreated controls. In model 2, the OARSI score at day 24 was not significantly different between treatment groups.Main limitations: Results from in vitro models cannot be directly translated to in vivo situations.Conclusions: In vitro treatment with conditioned serum did not alleviate IL‐1β‐induced responses in chondrocyte pellets or lead to morphological improvement in osteoarthritic cartilage explants.Keywords
This publication has 51 references indexed in Scilit:
- Effects of high mobility group box protein-1, interleukin-1β, and interleukin-6 on cartilage matrix metabolism in three-dimensional equine chondrocyte culturesConnective Tissue Research, 2010
- Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitroeffects on cartilage metabolism and intra-articular levels after injectionArthritis Research & Therapy, 2010
- Expression of Keratinocyte Growth Factor and Its Receptor in Rat Tracheal Cartilage: Possible Involvement in Wound Healing of the Damaged CartilageACTA HISTOCHEMICA ET CYTOCHEMICA, 2010
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodelingArthritis Research & Therapy, 2007
- Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signallingArthritis Research & Therapy, 2007
- OsteoarthritisJournal of Cellular Physiology, 2007
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdownArthritis & Rheumatism, 2001